胎盤と癌の侵入に対するストローム抵抗の並列進化の基礎となる遺伝子を特定する
Yasir Suhail1,2, Wenqiang Du3, Junaid Afzal4
1Department of Biomedical Engineering, UConn Health, Farmington, CT, USA. suhail@uchc.edu.
NPJ systems biology and applications
|August 22, 2025
まとめ
研究者達は 癌の拡散に影響を与える ストロマル遺伝子を特定しました これらの遺伝子は胎盤の侵入抵抗性に関連しており,癌の拡散を減らすための新しい治療標的を明らかにする可能性があります.
科学分野:
- 進化生物学
- 癌の研究
- 遺伝学
背景:
- ストロマ細胞は癌の広がりに関与しますが,特定の遺伝子は不明です.
- Epitheliochorial 種は胎盤の侵入に対する抵抗性を示し,低がん率と相関しています.
- ヒトの線維芽細胞におけるデシデュアライゼーションは,侵入に対する抵抗性も与えます.
研究 の 目的:
- 胎盤の侵入と決定化の経路を比較することによって,上皮の侵入を調節するストロマル遺伝子を特定する.
- 侵入に対するストロマの脆弱性に関連した遺伝子セット (ELI-D1) を開発する.
主な方法:
- 種間およびヒトの線維芽細胞におけるストロマル遺伝子の比較分析.
- ELI-D1遺伝子セットの作成と分析
- 転写レギュレータ候補の機能的検証 (Nr2f6,JDP2)
主要な成果:
- ELI-D1遺伝子セットは,発症前の早期癌変異 (T1-T2) 時にネガティブに濃縮された.
- Nr2f6とJDP2はヒトの線維芽細胞における侵入に対するストロマの抵抗を調節する物質として特定された.
- ヒトがんにおけるストロマの脆弱性に関連した遺伝子セットが確立された.
結論:
- 胎盤の侵入と決定化の収束経路は,がんの侵入を制御するストロマ遺伝子を特定することができます.
- ELI-D1遺伝子組と特定されたレギュレータは,ストロマの脆弱性と癌の拡散に関する洞察を提供します.
さらに関連する動画
06:36A Modified In vitro Invasion Assay to Determine the Potential Role of Hormones, Cytokines and/or Growth Factors in Mediating Cancer Cell Invasion
Published on: April 24, 2015
10.9K
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
8.5K
関連する概念動画
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
